Delivering drugs to specific, hard-to-reach areas in the human body remains a challenge in drug development. Typically, drug molecules administered via pills or injections circulate randomly through ...
Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...
A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...
These drugs, discovered decades ago, continue to save lives today, but more recent research has led to the development of ...
Synthetic cells that look just like natural cells but are chemically reversed could outcompete other living organisms − with ...
Authors Table of Contents Media Contact For general and media inquiries and to book our experts, please contact: [email protected] Harm reduction directly empowers people who use drugs to stay safer and ...
The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide ...
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
What foods and drinks look like — the colors we see before the first morsels or sips hit our tastebuds — have mattered to people for millennia. And nowhere has that been more blatant than the American ...
Nearly 22,000 pounds of fentanyl were seized at US borders during the 2024 fiscal year, according to data from the US Customs ...
Unlike opium, nitazenes and other synthetic opioids can be produced anywhere in the world using precursor chemicals that are often uncontrolled.
Ibogaine—a psychoactive plant derivative—has attracted attention for its anti-addictive and anti-depressant properties. But ...